NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

NPCE is currently covered by 5 analysts with an average price target of $16.13. This is a potential upside of $4.11 (34.19%) from yesterday's end of day stock price of $12.02.

Neuropace's activity chart (see below) currently has 83 price targets and 78 ratings on display. The stock rating distribution of NPCE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 67.37% of the time, taking 158.3 days on average.

Highest price target for NPCE is $22, Lowest price target is $7, average price target is $16.13.

Most recent stock forecast was given by MIKE KRATKY from LEERINK. First documented stock forecast 16-May-2021.

Best performing analysts who are covering NPCE - Neuropace:

Ross Osborn Priya Sachdeva Vik Chopra Yi Chen Frank Takkinen

Currently out of the existing stock ratings of NPCE, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-May-2025

$7

$-5.02 (-41.76%)

$20

3 days ago
(12-Nov-2026)

Buy Since 16-May-2021

$9

$-3.02 (-25.12%)

$16

3 days ago
(12-Nov-2026)

Buy Since 28-May-2024

$9

$-3.02 (-25.12%)

$16

3 days ago
(12-Nov-2026)

Buy Since 27-May-2025

$20

$7.98 (66.39%)

$20

3 months 18 days ago
(28-Jul-2026)

2/4 (50%)

$6.36 (46.63%)

222

Buy Since 20-Jan-2025

$22

$9.98 (83.03%)

$22

10 months 2 days ago
(13-Jan-2026)

2/4 (50%)

$5.25 (31.34%)

221

Show more analysts

Please expand the browser size to see the chart

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 158 days for the stock forecasts to be reached, with an average price target met ratio of 67.37%.

Which analyst most recently updated their price target on NPCE (Neuropace)?

Mike Kratky

Which analyst has the most public recommendations on NPCE (Neuropace)?

Mike Kratky has 5 price targets and 4 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Priya Sachdeva with the highest potential upside of $9.98

Which analyst is the currently most reserved on NPCE (Neuropace)?

Drew Ranieri with the lowest potential downside of -$8.47
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?